Studies with animal models have shown that local administration of THC or the synthetic cannabinoid WIN-55,212-2 reduced in vivo the size of the tumor generated by intracranial inoculation of C6-derived glioma in Wistar rats [26] with a concomitant involvement of CB1 and CB2 receptors. This evidence concerns the gene CNR1 and glioma.